RMD News and Press, ResMed Inc. From 11/09/23

Justin Leong appointed Chief Product Officer, effective immediately. Katrin Pucknat appointed Chief Marketing Officer, effective immediately. Mike Fliss appointed Chief Revenue Officer, effective immediately. Rob Douglas, President and Chief Operating Officer, to retire Ja...

2023-11-07 13:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-11-07 05:05:00 ET While the phrase "monster stocks" might generally have investors thinking of Tesla , Apple , or similar behemoths, the two businesses discussed in this article are sneakily monstrous. First, consumer health juggernaut Kenvue (NYSE: KVUE) produces a...

2023-11-04 11:08:35 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...

2023-10-30 06:00:00 ET Summary ResMed's shares have fallen 37% due to struggles with profitability and investor fears of weight loss drugs, but I believe in its long-term potential. The company reported a 16% increase in revenue and strong demand for its products, but margins were...

2023-10-27 23:25:41 ET Summary ResMed's share price has fallen by over 40% since highs hit in April 2023. GLP-1 weight-loss drugs are expected to reduce demand for ResMed's products that treat obstructive sleep apnea. FY23 operating conditions were very favourable for ResMed a...

2023-10-27 02:56:36 ET More on ResMed ResMed Inc. (RMD) Q1 2024 Earnings Call Transcript Here's The Price I'll Buy ResMed Stock ResMed - Trading Opportunity Now ResMed stock declines after hours on FQ1 revenue miss, gross margin contraction ResMed Non...

2023-10-26 21:52:09 ET ResMed Inc. (RMD) Q1 2024 Results Conference Call October 26, 2023 04:30 PM ET Company Participants Amy Wakeham - Chief Communications and Investor Relations Officer Mick Farrell - Chief Executive Officer Brett Sandercock - Chief Financial ...

2023-10-26 18:22:14 ET Shares of ResMed ( NYSE: RMD ) on Thursday slumped as much as 10.7% in extended trading, after the medical device company's quarterly gross margins came under pressure and its revenue missed estimates. RMD stock had pared some of its after hours losses...

2023-10-26 16:32:00 ET More on ResMed Here's The Price I'll Buy ResMed Stock ResMed - Trading Opportunity Now ResMed: Stock Re-Rating To 20x Forward P/E Is A Buy Opportunity ResMed Q1 2024 Earnings Preview ResMed upgraded at JPMorgan; says GLP-1 threa...